The price of vomitinib is 3304 yuan per box (40mg/28 capsules). Vomitinib is China’s independent research and development of the third generation of lung cancer targeted therapeutic drugs, the price is 3304 yuan per box (40mg/28 capsules), but the specific still need to combine with the local health insurance policy, reimbursement ratio and so on to determine. This drug is mainly used for the treatment of locally advanced or metastatic non-small cell lung cancer with EGFR-sensitive mutation, which can compete with endogenous ligands, bind EGFR, inhibit tyrosine kinase activity, block EGFR signaling, thus inhibiting the reproduction and metastasis of cancer cells and achieving therapeutic effect. Adverse reactions such as transaminase elevation and upper respiratory tract infection may occur during the use of the drug, and if the situation is serious, targeted treatment is required.